Trial Profile
Phase I Study on Safety, Tolerability and Immunogenicity of the MVA-BN Vaccine Administered to Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Adverse reactions
- Sponsors Bavarian Nordic
- 24 Sep 2014 New trial record